Lower riskDrug recall · FDA · Published September 9, 2021
Aurobindo Pharma Metoprolol Tablets Recall: Metal Wire in Some Tablets
Aurobindo Pharma recalls 100mg Metoprolol Tartrate tablets due to metal wire found in one tablet. This could cause injury if swallowed. Contact for return instructions.
“Aurobindo Pharma Metoprolol Tablets Recall: Metal Wire in Some Tablets.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35859-aurobindo-pharma-metoprolol-tablets-recall-metal-wire-in-some-tablets. Based on FDA recall #D-0812-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0812-2021%22&limit=1).
Aurobindo Pharma USA Inc. recalled Metoprolol Tartrate Tablets USP 100 mg due to the presence of metal wire in one tablet, according to the FDA. The Food and Drug Administration announced the Class II recall on September 9, 2021.
How to tell if you have it
Brand: Aurobindo Pharma
Product: Metoprolol Tartrate Tablets USP 100 mg
Packaging: 1000-count bottles
NDC: 65862-064-99
Lot code: MJ1019025-A
Expiration date: 04/2022
Quantity: 2,820 bottles
The hazard
The recall was initiated after product complaints were received regarding the presence of metal wire in one tablet. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Aurobindo Pharma USA Inc. has had 32 other recalls on record since April 9, 2013. Recent brand recalls include Dicyclomine Capsules recalled on July 23, 2026, due to empty capsules, and Acetaminophen Tablets recalled on May 22, 2025, for brown tablet discoloration risk. Other recent recalls of similar products include Guardian Drug Goodsense Ultra Strength Antacid Tablets Recall (May 28, 2026), Guardian Extra Strength Antacid Tablets Recall (May 28, 2026), and Guardian Drug TopCare Antacid Tablets Recall (May 28, 2026).
How to tell if you have this one
Check for the product name 'Metoprolol Tartrate Tablets USP 100 mg', 1000-count bottles, Rx only. The lot number MJ1019025-A and expiration date 04/2022 are specific to this recall.
Brand
Aurobindo Pharma
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop Using It Now
Discard the recalled tablets immediately to avoid potential injury from metal wire.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.1 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0812-2021 (September 9, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0812-2021 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.